Marksans Pharma Ltd. - Research Center
524404 MARKSANS Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Sep' 21 | Jun' 21 | Mar' 21 | Dec' 20 | Sep' 20 | |
|---|---|---|---|---|---|
| Sales | 168.85 | 147.22 | 137.58 | 168.46 | 137.55 |
| Operating profit | 33.93 | 25.10 | 26.78 | 34.88 | 23.05 |
| Interest | 1.20 | 0.63 | 2.14 | 1.10 | 1.32 |
| Gross profit | 41.33 | 38.41 | 36.55 | 40.03 | 34.68 |
| EPS (Rs) | 0.67 | 0.71 | 0.58 | 0.71 | 0.57 |
Quarterly
results in details
| Sep' 21 | Jun' 21 | Mar' 21 | Dec' 20 | Sep' 20 | |
|---|---|---|---|---|---|
| Other income | 8.60 | 13.94 | 11.91 | 6.24 | 12.96 |
| Stock adjustment | 1.15 | -0.66 | -4.60 | 5.08 | -0.36 |
| Raw material | 85.59 | 78.76 | 74.49 | 77.25 | 70.95 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 15.92 | 14.04 | 15.67 | 13.83 | 12.86 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 32.26 | 29.99 | 25.24 | 37.42 | 31.05 |
| Provisions made | - | - | - | - | - |
| Depreciation | 4.30 | 4.23 | 4.15 | 4.03 | 3.67 |
| Taxation | 9.42 | 5.27 | 8.72 | 6.89 | 7.48 |
| Net profit / loss | 27.60 | 28.91 | 23.69 | 29.10 | 23.53 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 40.93 | 40.93 | 40.93 | 40.93 | 40.93 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 20.09 | 17.05 | 19.46 | 20.71 | 16.76 |
| GPM (%) | 23.29 | 23.83 | 24.45 | 22.91 | 23.04 |
| NPM (%) | 15.55 | 17.94 | 15.85 | 16.66 | 15.64 |
© 2021 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis